KEROS THERAPEUTICS IN
59.67
08-10月-24 15:59:59
15 分の遅延
株式
-0.45
-0.75%
本日の幅
59.56 - 61.00
ISIN
N/A
ソース
NASDAQ
-
Keros Therapeutics to Present at the Jefferies Virtual London Healthcare Conference
11 11 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
08 11 2021 08:00:02 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2021 Financial Results
04 11 2021 09:01:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences
02 9 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
05 8 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Simon Cooper, M.B.B.S. as Chief Medical Officer
02 8 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
22 6 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
11 6 2021 08:00:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the Jefferies Virtual Healthcare Conference
27 5 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
25 5 2021 08:00:05 提供 Nasdaq GlobeNewswire
-
14 5 2021 08:00:00 提供 Nasdaq GlobeNewswire
-
12 5 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results
06 5 2021 16:01:02 提供 Nasdaq GlobeNewswire
-
25 3 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference
02 3 2021 08:00:02 提供 Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
17 2 2021 08:00:01 提供 Nasdaq GlobeNewswire